VAM
Visium Asset Management’s Neurocrine Biosciences NBIX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | – | Sell |
-4,837
| Closed | -$219K | – | 119 |
|
|
2016
Q2 | $219K | Sell |
4,837
-1,859,385
| -100% | -$84.2M | 0.02% | 266 |
|
|
2016
Q1 | $73.7M | Sell |
1,864,222
-337,628
| -15% | -$13.4M | 1.25% | 8 |
|
|
2015
Q4 | $125M | Buy |
2,201,850
+2,345
| +0.1% | +$133K | 1.87% | 5 |
|
|
2015
Q3 | $87.5M | Buy |
2,199,505
+192,322
| +10% | +$7.65M | 1.2% | 12 |
|
|
2015
Q2 | $95.9M | Sell |
2,007,183
-1,012,694
| -34% | -$48.4M | 1.36% | 9 |
|
|
2015
Q1 | $120M | Buy |
3,019,877
+558,037
| +23% | +$22.2M | 1.77% | 6 |
|
|
2014
Q4 | $55M | Buy |
2,461,840
+674,579
| +38% | +$15.1M | 0.78% | 20 |
|
|
2014
Q3 | $28M | Buy |
1,787,261
+2,840
| +0.2% | +$44.5K | 0.41% | 37 |
|
|
2014
Q2 | $26.5M | Sell |
1,784,421
-216,514
| -11% | -$3.21M | 0.41% | 42 |
|
|
2014
Q1 | $32.2M | Sell |
2,000,935
-113,495
| -5% | -$1.83M | 0.52% | 33 |
|
|
2013
Q4 | $19.7M | Buy |
2,114,430
+307,293
| +17% | +$2.87M | 0.39% | 54 |
|
|
2013
Q3 | $20.5M | Sell |
1,807,137
-141,083
| -7% | -$1.6M | 0.46% | 50 |
|
|
2013
Q2 | $26.1M | Buy |
+1,948,220
| New | +$26.1M | 0.61% | 35 |
|